Affinity DataIC50: 6nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells using FMZ as substrate by NanoLuc luciferase assayMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells using FMZ as substrate by NanoLuc luciferase assayMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells using FMZ as substrate by NanoLuc luciferase assayMore data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells using FMZ as substrate by NanoLuc luciferase assayMore data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells using FMZ as substrate by NanoLuc luciferase assayMore data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells using FMZ as substrate by NanoLuc luciferase assayMore data for this Ligand-Target Pair
Affinity DataIC50: 94nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 by ITC assayMore data for this Ligand-Target Pair
Affinity DataIC50: 94nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 by ITC assayMore data for this Ligand-Target Pair
Affinity DataIC50: 94nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 by ITC assayMore data for this Ligand-Target Pair
Affinity DataKd: 4.00E+3nMAssay Description:Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cellsMore data for this Ligand-Target Pair
Affinity DataKd: 0.0300nMAssay Description:Binding affinity of SARS-COV2 S-RBD by BLI assayMore data for this Ligand-Target Pair
Affinity DataKd: 1.30E+3nMAssay Description:Binding affinity of SARS-COV2 S-RBD by BLI assayMore data for this Ligand-Target Pair
Affinity DataKd: 2.00E+3nMAssay Description:Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cellsMore data for this Ligand-Target Pair
Affinity DataKd: 5.00E+3nMAssay Description:Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cellsMore data for this Ligand-Target Pair
Affinity DataKd: 2.00E+3nMAssay Description:Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cellsMore data for this Ligand-Target Pair
Affinity DataKd: 46nMAssay Description:Binding affinity to recombinant SARS-COV2 S-RBD incubated for 5 mins by microscale thermophoresis analysisMore data for this Ligand-Target Pair
Affinity DataKd: 2.20E+3nMAssay Description:Binding affinity to biotinylated recombinant SARS-COV2 S-RBD by SPR analysisMore data for this Ligand-Target Pair
Affinity DataKd: 541nMAssay Description:Binding affinity to recombinant SARS-COV2 S-RBD incubated for 5 mins by microscale thermophoresis analysisMore data for this Ligand-Target Pair
Affinity DataKd: 245nMAssay Description:Binding affinity to recombinant SARS-COV2 S-RBD incubated for 5 mins by microscale thermophoresis analysisMore data for this Ligand-Target Pair
Affinity DataKd: 102nMAssay Description:Binding affinity to recombinant SARS-COV2 S-RBD incubated for 5 mins by microscale thermophoresis analysisMore data for this Ligand-Target Pair
Affinity DataKd: 106nMAssay Description:Binding affinity to recombinant SARS-COV2 S-RBD incubated for 5 mins by microscale thermophoresis analysisMore data for this Ligand-Target Pair
Affinity DataKd: 13nMAssay Description:Binding affinity to recombinant SARS-COV2 S-RBD incubated for 5 mins by microscale thermophoresis analysisMore data for this Ligand-Target Pair